• Users Online: 112
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
BRIEF ARTICLE
Year : 2020  |  Volume : 22  |  Issue : 2  |  Page : 85-87

Lateral flow assay for the rapid detection of carbapenemases in Enterobacterales


1 Department of Microbiology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India
2 Department of Microbiology, Yashoda Hospitals – Somajiguda, Hyderabad, Telangana, India
3 Department of Medicine and Adult Injectious Diseases, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana, India, Telangana

Correspondence Address:
Dr. Kalyani Borde
Department of Microbiology, Apollo Institute of Medical Sciences and Research, Hyderabad, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jacm.jacm_31_21

Rights and Permissions

With the development of carbapenemase inhibitors such as avibactam, relebactam and vaborbactam, it has become important to detect the type of carbapenemase produced for guiding antibiotic therapy. Among the several methods available for the same, we chose lateral flow assay (Resist-3 O. K. N., Coris BioConcepts, Gembloux, Belgium) and compared it against a commercially available molecular test (Xpert Carba R assay, version 2, Cepheid, Sunnyvale, CA, USA). Sixteen clinical isolates, which were resistant to carbapenems on phenotypic testing, were selected. Fourteen of these were Klebsiella pneumoniae and two were Escherichia coli a total of 22 carbapenemases. (OXA-48-14, New Delhi metallo-beta-lactamase [NDM]-7 and K. pneumoniae carbapenemase [KPC]-1) were detected by the Carba-R assay. Six isolates (K. pneumoniae-5 and E. coli-1) had co-production of OXA-48 and NDM. Resist-3 assay detected all twenty two enzymes. The distribution of enzymes in these 16 isolates was identical to that shown by the Carba-R (100% agreement). Hence, we conclude that lateral flow immunochromatography assay is a simple, rapid and cost-effective method for the detection of carbapenemases. This would help the clinician select the appropriate antibiotic and support antibiotic stewardship in the Indian settings.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1182    
    Printed30    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal